Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial

01 Apr 2025

Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Elad Asher

Author

Elad Asher
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: Primary biomarker analysis from the EARLY TAVR Trial

New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

29 Mar 2025

Luigi Biasco provides his take on a sub-analysis of the Early TAVR trial about the early and delayed aortic valve replacement implant patients presented by Philippe Genereux at ACC.25 in Chicago.

Luigi Biasco

Author

Luigi Biasco
New insights from the early and delayed aortic valve replacement implant patients: a sub-analysis of the Early TAVR trial

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Yohei Ohno

Author

Yohei Ohno
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial

31 Mar 2025

Jonathan Curio interviews Raj Makkar about the results of the Align-AR trial which he presented during the ACC.25 in Chicago.

Jonathan Curio

Author

Jonathan Curio
Raj Makkar

Author

Raj Makkar
Clinical and echocardiographic outcomes among the first 500 patients treated with a dedicated transcatheter aortic valve for pure aortic regurgitation in the Align-AR clinical trial

Routine cerebral embolic protection in transcatheter aortic valve implantation: the British Heart Foundation (BHF) PROTECT-TAVI trial

29 Mar 2025

Aaysha Cader and Ali Nazmi Calik provide their take on the BHF PROTECT-TAVI trial, presented by Rajesh Kharbanda at ACC.25 in Chicago.

Author

Aaysha Cader

Author

Ali Nazmi Calik
Routine cerebral embolic protection in TAVI: the British Heart Foundation (BHF) PROTECT-TAVI trial

Dapagliflozin in patients undergoing transcatheter aortic valve implantation (DapaTAVI)

10 Apr 2025

Chiara De Biase interviews Sergio Raposeiras-Roubin about the results of the DapaTAVI trial which he presented during the ACC.25 in Chicago.

Author

Chiara De Biase
Sergio Raposeiras-Roubin

Author

Sergio Raposeiras-Roubin
Dapagliflozin in patients undergoing transcatheter aortic valve implantation (DapaTAVI)

Periprocedural management: TAVI

09 Feb 2025 – From PCR Tokyo Valves 2025

Want to elevate your expertise in TAVI periprocedural management? This session (in Japanese) is for you!

Discover the essential skills every team member needs for a smooth and successful TAVI procedure. Learn how radiologic technologists optimize imaging, how medical laboratory technologists provide critical real-time data, and how...

Periprocedural management: TAVI

Hot topics in TAVI

09 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest hot topics in TAVI, including the impact of balloon-expandable TAVR valve deformation and calcium distribution on outcomes in bicuspid aortic valve, the outcomes of complex and high-risk vs. standard PCI in TAVI patients, hemodynamic outcomes after TAVI for aortic stenosis with small annuli,...

Hot topics in TAVI

Lifetime management with self-expandable valve based on the latest evidence

09 Feb 2025 – From PCR Tokyo Valves 2025

Explore the latest evidence on the Evolut system and its impact on long-term valve durability in TAVR. Gain insights into its use for TAV-in-SAV procedures, the role of valve design in optimizing outcomes, and the importance of first-valve selection, commissure alignment, and coronary access.

Lifetime management with self-expandable valve based on the latest evidence

Combined valve disease

09 Feb 2025 – From PCR Tokyo Valves 2025

This session delves into the management of combined valve disease, covering topics such as transcatheter tricuspid valve replacement and valve-in-valve/valve-in-ring implantation in high-risk patients, the importance of CT imaging analysis in predicting true mitral stenosis in TAVI patients, the clinical outcomes of mild-to-moderate mixed aortic valve...

Combined valve disease

TAVI in challenging anatomy

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the challenges of TAVI in complex anatomies, including cases of extremely horizontal aorta, extra-large aortic annulus with calcified amorphous tumour-like mass, severe atherosclerotic aorta complicated by severe aortic stenosis, transfemoral TAVI for severe aortic regurgitation with Stanford type B aortic dissection, and optimal TAVI...

TAVI in challenging anatomy

Sharper views, smarter moves: mini 4D TEE and 4D ICE in structural heart interventions

09 Feb 2025 – From PCR Tokyo Valves 2025

Don’t miss this PCR Tokyo Valves 2025 session replay, where experts dive into the clinical benefits of the Mini 4D TEE Probe in TAVR and LAAC procedures. Learn how this miniaturised probe enhances patient outcomes in TAVR, contributing to more efficient procedures and improved safety. Discover...

Sharper views, smarter moves: mini 4D TEE and 4D ICE in structural heart interventions

Imaging aortic valve

09 Feb 2025 – From PCR Tokyo Valves 2025

Explore cutting-edge imaging techniques to assess and guide the management of aortic valve disease in this comprehensive session. From preprocedural assessment with TEE to advanced CT and MRI strategies, learn how to evaluate and treat patients with low-flow low-gradient aortic stenosis, aortic regurgitation, and post-TAVI complications....

Imaging aortic valve

TAVI abstracts

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the latest TAVI-related research and advancements. Explore studies on optimizing hemostasis during TAVI, the safety and efficacy of TAVI in Filipino patients, the outcomes of TAVI in hemodialysis patients, and the effectiveness of patient education videos for TAVI. Stay up-to-date with the latest developments...

TAVI abstracts

Coronary access after TAVI: timing and techniques

09 Feb 2025 – From PCR Tokyo Valves 2025

Struggling with PCI after TAVI? This session breaks it down with 3 real-world cases. You'll learn when and how to perform revascularization in severe AS patients, the impact of commissure alignment on future coronary access, and expert techniques for post-TAVI PCI:

  • Case 1: Managing a patient with...
Coronary access after TAVI: timing and techniques

Expanding indications for TAVI - moderate aortic stenosis and heart failure

09 Feb 2025 – From PCR Tokyo Valves 2025

Should you intervene earlier in patients with moderate aortic stenosis and heart failure? This session breaks down the latest trials shaping clinical decisions.

You'll get the key takeaways from EARLY TAVR, EVOLVED, TAVR UNLOAD, PROGRESS and EXPAND TAVR II (what they reveal, what they don’t and how...

Expanding indications for TAVI - moderate aortic stenosis and heart failure

Complex anatomical features

09 Feb 2025 – From PCR Tokyo Valves 2025

Dive into a captivating session that explores complex anatomical features in interventional cardiology. Discover dynamic improvements in tricuspid valve coaptation and regurgitation post-TAVI, the overlooked threat of aortic stenosis hidden by mitral stenosis, marked improvement in left ventricular function after simultaneous TAVI and M-TEER, recognition of...

Complex anatomical features

Challenging TAVI

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into this captivating session that explores challenging TAVI procedures. Witness the management of a patient with pure aortic regurgitation and previous mitral valve replacement, an extremely challenging transfemoral TAVI, the management of bradycardia before TAVI in a patient with MVR and TVR, a case of...

Challenging TAVI

TAV-in-SAV - Part 2

09 Feb 2025 – From PCR Tokyo Valves 2025

Delve into the second part of the TAV-in-SAV session, where you'll discover the reproducible BASILICA technique using an enface view, chimney stenting during TAV-in-SAV in a high coronary occlusion risk patient, urgent zero contrast TAV-in-SAV, a tale of a complication where you shouldn't BASILICA the new...

TAV-in-SAV - Part 2

Valve in valve in small degenerative surgical bioprosthesis - LIVE case

09 Feb 2025 – From PCR Tokyo Valves 2025

A 74-year-old female with a permanent pacemaker and preserved LV function presented with a symptomatic degenerative surgical valve (SJ Epic 21) implanted in 2016.
Patient underwent implantation of an Evolut FX 26 mm under general anesthesia with cerebral embolic protection and TEE guidance. A surgical valve fracture...

Valve in valve in small degenerative surgical bioprosthesis - LIVE case